Uncategorized
Amgen stands by rare disease drug Tavneos amid Japan liver toxicity report
Amgen stands by rare disease drug Tavneos amid Japan liver toxicity report
The FDA wants it off the market. European regulators are investigating data-integrity concerns. And now, a pharma company selling the drug in Japan is warning doctors against writing new prescriptions.
Still, Amgen remains resolute in … Read More